Use of Vascular Shunt at the Time of Pancreatectomy with Venous Resection: A Systematic Review
Abstract
:Simple Summary
Abstract
1. Introduction
1.1. The Role of Surgical Shunts in the Era of Complex Pancreatic Surgery
1.2. The Mesocaval Shunt
1.3. The Mesoportal Shunt
1.4. The Distal Spleno-Renal Shunt and the Underestimate Impact of Left-Sided Portal Hypertension
2. Materials and Methods
2.1. Database Search
2.2. Study Selection and Data Extraction
2.3. Outcomes
2.4. Meta-Analysis
2.5. Risk of Bias Assessment
3. Results
Risk of Bias Assessment
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
Abbreviations
References
- Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer Statistics, 2016. CA Cancer J. Clin. 2016, 66, 7–30. [Google Scholar] [CrossRef] [PubMed]
- Oettle, H.; Post, S.; Neuhaus, P.; Gellert, K.; Langrehr, J.; Ridwelski, K.; Schramm, H.; Fahlke, J.; Zuelke, C.; Burkart, C.; et al. Adjuvant Chemotherapy with Gemcitabine vs Observation in Patients Undergoing Curative-Intent Resection of Pancreatic Cancer: A Randomized Controlled Trial. JAMA 2007, 297, 267–277. [Google Scholar] [CrossRef]
- Wysocka, O.; Kulbacka, J.; Saczko, J. Adjuvant, Neoadjuvant, and Experimental Regimens in Overcoming Pancreatic Ductal Adenocarcinoma. Prz. Gastroenterol. 2016, 11, 155–162. [Google Scholar] [CrossRef] [PubMed]
- Hackert, T.; Hinz, U.; Pausch, T.; Fesenbeck, I.; Strobel, O.; Schneider, L.; Fritz, S.; Büchler, M.W. Postoperative Pancreatic Fistula: We Need to Redefine Grades B and C. Surgery 2016, 159, 872–877. [Google Scholar] [CrossRef] [PubMed]
- Orloff, M.J.; Bell, R.H., Jr.; Hyde, P.V.; Skivolocki, W.P. Long-Term Results of Emergency Portacaval Shunt for Bleeding Esophageal Varices in Unselected Patients with Alcoholic Cirrhosis. Ann. Surg. 1980, 192, 325–340. [Google Scholar] [CrossRef] [PubMed]
- Chavez, M.I.; Tsai, S.; Clarke, C.N.; Aldakkak, M.; Griffin, M.O.; Khan, A.H.; Ritch, P.S.; Erickson, B.A.; Evans, D.B.; Christians, K.K. Distal Splenorenal and Mesocaval Shunting at the Time of Pancreatectomy. Surgery 2019, 165, 298–306. [Google Scholar] [CrossRef] [PubMed]
- Warren, W.D.; Zeppa, R.; Fomon, J.J. Selective Trans-Splenic Decompression of Gastroesophageal Varices by Distal Splenorenal Shunt. Ann. Surg. 1967, 166, 437–455. [Google Scholar] [CrossRef] [PubMed]
- Varadhachary, G.R.; Tamm, E.P.; Abbruzzese, J.L.; Xiong, H.Q.; Crane, C.H.; Wang, H.; Lee, J.E.; Pisters, P.W.T.; Evans, D.B.; Wolff, R.A. Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy. Ann. Surg. Oncol. 2006, 13, 1035–1046. [Google Scholar] [CrossRef]
- Callery, M.P.; Chang, K.J.; Fishman, E.K.; Talamonti, M.S.; William Traverso, L.; Linehan, D.C. Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement. Ann. Surg. Oncol. 2009, 16, 1727–1733. [Google Scholar] [CrossRef]
- Bockhorn, M.; Uzunoglu, F.G.; Adham, M.; Imrie, C.; Milicevic, M.; Sandberg, A.A.; Asbun, H.J.; Bassi, C.; Büchler, M.; Charnley, R.M.; et al. Borderline Resectable Pancreatic Cancer: A Consensus Statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2014, 155, 977–988. [Google Scholar] [CrossRef]
- Addeo, P.; De Mathelin, P.; Averous, G.; Tambou-Nguipi, M.; Terrone, A.; Schaaf, C.; Dufour, P.; Bachellier, P. The Left Splenorenal Venous Shunt Decreases Clinical Signs of Sinistral Portal Hypertension Associated with Splenic Vein Ligation during Pancreaticoduodenectomy with Venous Resection. Surgery 2020, 168, 267–273. [Google Scholar] [CrossRef] [PubMed]
- Bachellier, P.; Rosso, E.; Fuchshuber, P.; Addeo, P.; David, P.; Oussoultzoglou, E.; Lucescu, I. Use of a Temporary Intraoperative Mesentericoportal Shunt for Pancreatic Resection for Locally Advanced Pancreatic Cancer with Portal Vein Occlusion and Portal Hypertension. Surgery 2014, 155, 449–456. [Google Scholar] [CrossRef] [PubMed]
- Al-Saeedi, M.; Frank-Moldzio, L.; Contin, P.; Mayer, P.; Loos, M.; Schmidt, T.; Schneider, M.; Müller-Stich, B.P.; Berchtold, C.; Mehrabi, A.; et al. Splenorenal Shunt for Reconstruction of the Gastric and Splenic Venous Drainage during Pancreatoduodenectomy with Resection of the Portal Venous Confluence. Langenbecks. Arch. Surg. 2021, 406, 2535–2543. [Google Scholar] [CrossRef] [PubMed]
- Oehme, F.; Distler, M.; Müssle, B.; Kahlert, C.; Weitz, J.; Welsch, T. Results of Portosystemic Shunts during Extended Pancreatic Resections. Langenbecks. Arch. Surg. 2019, 404, 959–966. [Google Scholar] [CrossRef] [PubMed]
- Christians, K.K.; Riggle, K.; Keim, R.; Pappas, S.; Tsai, S.; Ritch, P.; Erickson, B.; Evans, D.B. Distal Splenorenal and Temporary Mesocaval Shunting at the Time of Pancreatectomy for Cancer: Initial Experience from the Medical College of Wisconsin. Surgery 2013, 154, 123–131. [Google Scholar] [CrossRef] [PubMed]
- Pilgrim, C.H.C.; Tsai, S.; Evans, D.B.; Christians, K.K. Mesocaval Shunting: A Novel Technique to Facilitate Venous Resection and Reconstruction and Enhance Exposure of the Superior Mesenteric and Celiac Arteries during Pancreaticoduodenectomy. J. Am. Coll. Surg. 2013, 217, e17–e20. [Google Scholar] [CrossRef] [PubMed]
- Krepline, A.N.; Christians, K.K.; Duelge, K.; Mahmoud, A.; Ritch, P.; George, B.; Erickson, B.A.; Foley, W.D.; Quebbeman, E.J.; Turaga, K.K.; et al. Patency Rates of Portal Vein/superior Mesenteric Vein Reconstruction after Pancreatectomy for Pancreatic Cancer. J. Gastrointest. Surg. 2014, 18, 2016–2025. [Google Scholar] [CrossRef] [PubMed]
- Addeo, P.; Nappo, G.; Felli, E.; Oncioiu, C.; Faitot, F.; Bachellier, P. Management of the Splenic Vein during a Pancreaticoduodenectomy with Venous Resection for Malignancy. Updates Surg. 2016, 68, 241–246. [Google Scholar] [CrossRef] [PubMed]
- Miura, F.; Takada, T.; Asano, T.; Kenmochi, T.; Ochiai, T.; Amano, H.; Yoshida, M. Hemodynamic Changes of Splenogastric Circulation after Spleen-Preserving Pancreatectomy with Excision of Splenic Artery and Vein. Surgery 2005, 138, 518–522. [Google Scholar] [CrossRef]
- Conway, W.C.; Bolton, J.S. Mesocaval Shunt to Facilitate Complex Venous Resection during Pancreaticoduodenectomy. Am. Surg. 2014, 80, 1179–1181. [Google Scholar] [CrossRef]
- Sgroi, M.D.; Narayan, R.R.; Lane, J.S.; Demirjian, A.; Kabutey, N.-K.; Fujitani, R.M.; Imagawa, D.K. Vascular Reconstruction Plays an Important Role in the Treatment of Pancreatic Adenocarcinoma. J. Vasc. Surg. 2015, 61, 475–480. [Google Scholar] [CrossRef] [PubMed]
- Lemke, J.; Schmidt, S.A.; Kornmann, M.; Orend, K.-H.; Henne-Bruns, D. Challenging the Limits in Pancreatic Surgery: A Case Report. Int. J. Surg. Case Rep. 2016, 29, 151–154. [Google Scholar] [CrossRef] [PubMed]
- Ettorre, G.M.; Levi Sandri, G.B.; Colasanti, M.; de Werra, E.; Lepiane, P. Distal Pancreatectomy with Splenorenal Shunt to Preserve Spleen in a Cirrhotic Patient. Ann. Hepatobiliary Pancreat. Surg. 2017, 21, 93–95. [Google Scholar] [CrossRef] [PubMed]
- Pizanias, M.; Kontis, E.; Prassas, E.; Srinivasan, P.; Prachalias, A. Surgical Portosystemic Shunts to Facilitate Major Intrabdominal Surgery. Hepatobiliary Pancreat. Dis. Int. 2019, 18, 488–490. [Google Scholar] [CrossRef] [PubMed]
- Gautham, M.S.; Gnanasekaran, S.; Raja, K.; Pottakkat, B. Transient Mesoportal Shunt: An Innovative Technique for Maintaining Portal Flow during Pancreatoduodenectomy with Portal Vein Resection. Ann. Hepatobiliary Pancreat. Surg. 2021, 25, 122–125. [Google Scholar]
- Aoyama, R.; Hori, T.; Yamamoto, H.; Harada, H.; Yamamoto, M.; Yamada, M.; Yazawa, T.; Sasaki, B.; Tani, M.; Sato, A.; et al. A Thought-Provoking Case of Successfully Treated Carcinoma of the Head of the Pancreas with Metachronous Lung Metastasis: Impact of Distal Spleno-Renal Shunt for Regional Invasion on Long-Term Period after Pancreaticoduodenectomy. Case Rep. Surg. 2021, 2021, 6689419. [Google Scholar] [CrossRef] [PubMed]
- Ito, K.; Kudo, A.; Nakamura, N.; Tanaka, S.; Teramoto, K.; Arii, S. Left-Sided Portal Hypertension Caused by Serous Cystadenoma of the Pancreas: Report of a Case. Surg. Today 2008, 38, 184–187. [Google Scholar] [CrossRef] [PubMed]
- Kagota, S.; Shimizu, T.; Taniguchi, K.; Tomioka, A.; Inoue, Y.; Komeda, K.; Asakuma, M.; Lee, S.-W.; Hirokawa, F.; Uchiyama, K. Surgical Treatment of Gastric Venous Congestion in Association with Extended Resection of Pancreas: A Case Report. BMC Surg. 2020, 20, 28. [Google Scholar] [CrossRef]
- Kinny-Köster, B.; Habib, J.R.; van Oosten, F.; Javed, A.A.; Cameron, J.L.; Burkhart, R.A.; Burns, W.R.; He, J.; Wolfgang, C.L. Conduits in Vascular Pancreatic Surgery: Analysis of Clinical Outcomes, Operative Techniques, and Graft Performance. Ann. Surg. 2023, 278, e94–e104. [Google Scholar] [CrossRef]
- Schmidt, T.; Strobel, O.; Schneider, M.; Diener, M.K.; Berchtold, C.; Mihaljevic, A.L.; Mehrabi, A.; Müller-Stich, B.P.; Hackert, T.; Büchler, M.W. Cavernous Transformation of the Portal Vein in Pancreatic Cancer Surgery-Venous Bypass Graft First. Langenbecks. Arch. Surg. 2020, 405, 1045–1050. [Google Scholar] [CrossRef]
- Tang, R.; Yang, W.; Hou, Y.; Yu, L.; Wu, G.; Tong, X.; Yan, J.; Lu, Q. Augmented Reality-Assisted Pancreaticoduodenectomy with Superior Mesenteric Vein Resection and Reconstruction. Gastroenterol. Res. Pract. 2021, 2021, 9621323. [Google Scholar] [CrossRef]
- Christians, K.K. Commentary: Venous Resection and Reconstruction at the Time of Pancreatectomy for Cancer. Surgery 2020, 168, 1058–1059. [Google Scholar] [CrossRef]
- Hori, T.; Aoyama, R.; Yamamoto, H.; Harada, H.; Yamamoto, M.; Yamada, M.; Yazawa, T.; Zaima, M. Sinistral Portal Hypertension and Distal Splenorenal Shunt during Pancreatic Surgery. Hepatobiliary Pancreat. Dis. Int. 2022, 21, 73–75. [Google Scholar] [CrossRef] [PubMed]
- Ito, H.; Takahashi, Y.; Saiura, A. Commentary: Complex Venous Resection and Reconstruction for Locally Advanced Pancreatic Cancer: Our Approach. Surgery 2020, 168, 1056–1057. [Google Scholar] [CrossRef] [PubMed]
- Addeo, P.; Bachellier, P. Pancreaticoduodenectomy with Segmental Venous Resection: A Standardized Technique Avoiding Graft Interposition. J. Gastrointest. Surg. 2021, 25, 1925–1931. [Google Scholar] [CrossRef]
- Kaneoka, Y.; Maeda, A.; Isogai, M. Surgical Outcome of Autologous External Iliac Vein Grafting in Cases of Hepato-Pancreato-Biliary Malignancy: How I Do It. J. Gastrointest. Surg. 2012, 16, 1590–1596. [Google Scholar] [CrossRef]
- Ono, Y.; Inoue, Y.; Kato, T.; Matsueda, K.; Oba, A.; Sato, T.; Ito, H.; Saiura, A.; Takahashi, Y. Sinistral Portal Hypertension after Pancreaticoduodenectomy with Splenic Vein Resection: Pathogenesis and Its Prevention. Cancers 2021, 13, 5334. [Google Scholar] [CrossRef]
- Ono, Y.; Tanaka, M.; Matsueda, K.; Hiratsuka, M.; Takahashi, Y.; Mise, Y.; Inoue, Y.; Sato, T.; Ito, H.; Saiura, A. Techniques for Splenic Vein Reconstruction after Pancreaticoduodenectomy with Portal Vein Resection for Pancreatic Cancer. HPB 2019, 21, 1288–1294. [Google Scholar] [CrossRef]
- Simoneau, E.; Katz, M.H.; Lee, J.E.; Tzeng, C.-W.D. ASO Author Reflections: Temporary Mesocaval Shunt: Indications and Technique for Safe Resection of Pancreatic Tumors With Mesenteric Venous Occlusion. Ann. Surg. Oncol. 2019, 26, 579–580. [Google Scholar] [CrossRef] [PubMed]
- Tuech, J.J.; Pessaux, P.; Arnaud, J.P. Portal Vein Resection in Pancreatic Head Carcinoma. Part 1: Technical Considerations. Hepatogastroenterology 2001, 48, 884–887. [Google Scholar] [PubMed]
- Conneely, J.B.; Smoot, R.L.; Greig, P.D.; McGilvray, I.D. Mesocaval Shunting. J. Am. Coll. Surg. 2014, 218, 306–307. [Google Scholar] [CrossRef] [PubMed]
- Younan, G.; Tsai, S.; Evans, D.B.; Christians, K.K. Techniques of Vascular Resection and Reconstruction in Pancreatic Cancer. Surg. Clin. N. Am. 2016, 96, 1351–1370. [Google Scholar] [CrossRef] [PubMed]
- Simoneau, E.; Goumard, C.; Lee, J.E.; Vauthey, J.-N.; Aloia, T.A.; Chun, Y.S.; Kim, M.P.; Katz, M.H.G.; Tzeng, C.-W.D. Pancreaticoduodenectomy with Mesocaval Shunt for Locally Advanced Pancreatic Adenocarcinoma. Ann. Surg. Oncol. 2019, 26, 652. [Google Scholar] [CrossRef] [PubMed]
- Tanaka, M.; Ito, H.; Ono, Y.; Matsueda, K.; Mise, Y.; Ishizawa, T.; Inoue, Y.; Takahashi, Y.; Hiratsuka, M.; Unno, T.; et al. Impact of Portal Vein Resection with Splenic Vein Reconstruction after Pancreatoduodenectomy on Sinistral Portal Hypertension: Who Needs Reconstruction? Surgery 2019, 165, 291–297. [Google Scholar] [CrossRef] [PubMed]
- Kinny-Köster, B.; van Oosten, F.; Habib, J.R.; Javed, A.A.; Cameron, J.L.; Lafaro, K.J.; Burkhart, R.A.; Burns, W.R.; He, J.; Fishman, E.K.; et al. Mesoportal Bypass, Interposition Graft, and Mesocaval Shunt: Surgical Strategies to Overcome Superior Mesenteric Vein Involvement in Pancreatic Cancer. Surgery 2020, 168, 1048–1055. [Google Scholar] [CrossRef] [PubMed]
- Christians, K.K.; Evans, D.B. Pancreaticoduodenectomy and Vascular Reconstruction: Indications and Techniques. Surg. Oncol. Clin. N. Am. 2021, 30, 731–746. [Google Scholar] [CrossRef]
- Nakao, A.; Harada, A.; Nonami, T.; Kaneko, T.; Takagi, H. Regional Vascular Resection Using Catheter Bypass Procedure for Pancreatic Cancer. Hepatogastroenterology 1995, 42, 734–739. [Google Scholar] [PubMed]
- Nakao, A.; Nonami, T.; Harada, A.; Kasuga, T.; Takagi, H. Portal Vein Resection with a New Antithrombogenic Catheter. Surgery 1990, 108, 913–918. [Google Scholar]
- Suzuki, Y.; Yoshida, I.; Ku, Y.; Fujino, Y.; Tanioka, Y.; Fukumoto, T.; Iwasaki, T.; Tominaga, M.; Kuroda, Y. Safety of Portal Vein Resection Using Centrifugal Pump-Assisted Venous Bypass between the Superior Mesenteric Vein and the Umbilical Vein. Hepatogastroenterology 2004, 51, 1183–1186. [Google Scholar]
- Kuroda, Y.; Tanioka, Y.; Ku, Y.; Fukumoto, T.; Tominaga, M.; Saitoh, M.; Suzuki, Y.; Tseng, A.; Saitoh, Y. Centrifugal Pump-Assisted Venous Bypass between the Superior Mesenteric Vein and the Umbilical Vein during Portal Vein Resection. Surg. Today 1996, 26, 762–764. [Google Scholar] [CrossRef]
- Evans, D.B.; Ritch, P.S.; Erickson, B.A. Neoadjuvant Therapy for Localized Pancreatic Cancer: Support Is Growing? Ann. Surg. 2015, 261, 18–20. [Google Scholar] [CrossRef]
- Hackert, T.; Schneider, L.; Büchler, M.W. Current State of Vascular Resections in Pancreatic Cancer Surgery. Gastroenterol. Res. Pract. 2015, 2015, 120207. [Google Scholar] [CrossRef]
- Wang, X.; Demir, I.E.; Schorn, S.; Jäger, C.; Scheufele, F.; Friess, H.; Ceyhan, G.O. Venous Resection during Pancreatectomy for Pancreatic Cancer: A Systematic Review. Transl. Gastroenterol. Hepatol. 2019, 4, 46. [Google Scholar] [CrossRef]
- Carrère, N.; Sauvanet, A.; Goere, D.; Kianmanesh, R.; Vullierme, M.-P.; Couvelard, A.; Ruszniewski, P.; Belghiti, J. Pancreaticoduodenectomy with Mesentericoportal Vein Resection for Adenocarcinoma of the Pancreatic Head. World J. Surg. 2006, 30, 1526–1535. [Google Scholar] [CrossRef]
- Evans, G.R.; Yellin, A.E.; Weaver, F.A.; Stain, S.C. Sinistral (left-Sided) Portal Hypertension. Am. Surg. 1990, 56, 758–763. [Google Scholar]
- Strasberg, S.M.; Bhalla, S.; Sanchez, L.A.; Linehan, D.C. Pattern of Venous Collateral Development after Splenic Vein Occlusion in an Extended Whipple Procedure: Comparison with Collateral Vein Pattern in Cases of Sinistral Portal Hypertension. J. Gastrointest. Surg. 2011, 15, 2070–2079. [Google Scholar] [CrossRef]
- Rosado, I.D.; Bhalla, S.; Sanchez, L.A.; Fields, R.C.; Hawkins, W.G.; Strasberg, S.M. Pattern of Venous Collateral Development after Splenic Vein Occlusion in an Extended Whipple Procedure (Whipple at the Splenic Artery) and Long-Term Results. J. Gastrointest. Surg. 2017, 21, 516–526. [Google Scholar] [CrossRef]
- Loos, M.; Mehrabi, A.; Ramouz, A.; Contin, P.; Strobel, O.; Müller-Stich, B.P.; Mihaljevic, A.L.; Diener, M.K.; Schneider, M.; Berchtold, C.; et al. Gastric Venous Congestion After Total Pancreatectomy Is Frequent and Dangerous. Ann. Surg. 2022, 276, e896–e904. [Google Scholar] [CrossRef]
- Shapey, I.M.; Sultan, M. Machine Learning for Prediction of Postoperative Complications after Hepato-Biliary and Pancreatic Surgery. OAE Publishing Inc. 2023, 3, 1–13. [Google Scholar] [CrossRef]
- De Robertis, R.; Todesco, M.; Autelitano, D.; Spoto, F.; D’Onofrio, M. The Role of Radiomics in Hepato-Bilio-Pancreatic Surgery: A Literature Review. Art. Int. Surg. 2023, 3, 166–179. [Google Scholar] [CrossRef]
- Fang, C.-H.; Zhu, W.; Wang, H.; Xiang, N.; Fan, Y.; Yang, J.; Wang, X.; Zhong, S.Z. A New Approach for Evaluating the Resectability of Pancreatic and Periampullary Neoplasms. Pancreatology 2012, 12, 364–371. [Google Scholar] [CrossRef]
- De Robertis, R.; Tomaiuolo, L.; Pasquazzo, F.; Geraci, L.; Malleo, G.; Salvia, R.; D’Onofrio, M. Correlation between ADC Histogram-Derived Metrics and the Time to Metastases in Resectable Pancreatic Adenocarcinoma. Cancers 2022, 14, 6050. [Google Scholar] [CrossRef]
- Stott, M.; Kausar, A. Can 3D Visualisation and Navigation Techniques Improve Pancreatic Surgery? A Systematic Review. Artif. Intell. Surg. 2023, 3, 207–216. [Google Scholar] [CrossRef]
- de Muynck, L.D.A.N.; White, K.P.; Alseidi, A.; Bannone, E.; Boni, L.; Bouvet, M.; Falconi, M.; Fuchs, H.F.; Ghadimi, M.; Gockel, I.; et al. Consensus Statement on the Use of Near-Infrared Fluorescence Imaging during Pancreatic Cancer Surgery Based on a Delphi Study: Surgeons’ Perspectives on Current Use and Future Recommendations. Cancers 2023, 15, 652. [Google Scholar] [CrossRef]
Author, Year | Operative Time (min) | Blood Loss (mL) | Complications | Shunt Patency | LOS Days | R0 | Mortality |
---|---|---|---|---|---|---|---|
Addeo et al. [11] | 600 +/- 128 | NR | 23/78 | 76/78 | NR | 36/78 | 1 |
Chavez et al. [6] | Median 540 (390–780) | Median 950 mL (200–5.000) | 4/31 * | 19/20 | Median 11 days (7–35) | 30/31 | 0 |
Bachellier et al. [12] | 659 +/- 118 | 850 +/- 1200 mL (range 420–4300) | 7/15 § | NA | NR | 12/15 | 0 |
Al-Saeedi et al. [13] | 430.7 ± 146.2 | 1200 ± 600 | 5/10 # | 6/10 | 27.2 +/- 23.4 | 3/10 | 1 |
Oehme et al. [14] | Median 566 (459–671) | Median 1800 mL (525–3075) | 5/11 ° | 4/7 | NR | 10/11 | 1 |
Author, Year | Neoadjuvant Therapy | |
---|---|---|
N. Patients | Type of Neoadjuvant Therapy | |
Addeo et al. [11] | 45/78 | Chemotherapy |
Chavez et al. [6] | 29/31 | 26 PDAC chemotherapy+chemoradiation, 1 PDAC chemotherapy. 1 PNET chemotherapy, 1 PNET chemo+chemoradiotherapy |
Bachellier et al. [12] | 15/15 | Chemotherapy (8 FOLFIRINOX + 7 GEMOX) |
Al-Saeedi et al. [13] | 3/10 | Chemotherapy/radiotherapy |
Oehme et al. [14] | 4/11 | Chemotherapy (3 FOLFIRINOX, 1 gemcitabine) |
Author, Year | Associated Arterial Resection | Surgery | Shunt | Type of Shunt | Time of Clamping | Duration of Shunt | Anticoagulation | Reconstruction |
---|---|---|---|---|---|---|---|---|
Addeo et al. [11] | 20/78 SMA, 14/78 HA | 78 PD | 78 DSRS | end-to-side SV-LRV anastomosis | NR | Definitive | NR | SMV-PV direct anastomosis |
Chavez et al. [6] | 2 CHA | PD 18, TP 6, EXTENDED PD 7 | 16 DSRS, 12 MCS, 2 COMBINED, 1 SAS | 14 LIJV | NR | Temporary, Definitive | Heparin and aspirin | Primary end-to-end SMV-PV; SMV-PV with internal jugular vein interposition graft, SMV-IJV-IVC 3 patients who had permanent MCS |
Bachellier et al. [12] | 7 SMA, 2 CHA, 1 CHA + LHA, 1 CT | 12 PD, 3 TP | 15 TMPS | Gore-Tex | 25 ± 2 min (range, 18–27) | Temporary | No systemic heparinization during and after | End-to-end PV/SMV anastomosis |
Al-Saeedi et al. [13] | 4/10 | 6 PD, 4 TP spleen preserving | 10 DSRS | end-to-side SV-LRV anastomosis | 5–15 min | Definitive | Thrombosis prophylaxis with low molecular heparin weight following surgery until discharge, No use of antiplatelet agent | SMV-PV end-to-end 5–0 or 6–0 monofilament nonabsorbable running suture |
Oehme et al. [14] | 5 CHA, 1 RHA | 7 PD, 4 TP | 5 DSRS, 4 MCS, 1 SCS, 1 COMBINED * | DSRS (end-to-side SV-LRV anastomosis), MCS (3LIJV, 1 bovine patch) | NR | Temporary, Definitive | NR | Primary end-to-end SMV-PV; SMV-PV with internal jugular vein interposition graft |
Author, Year | Study Design | Study Location | Time of Enrollment | N | F | M | Age | Diagnosis |
---|---|---|---|---|---|---|---|---|
Addeo et al. [11] | Case-control | France | 2012–2018 | 78 * | NR | NR | 63 +/- 8.1 | 68/78 PDAC |
Chavez et al. [6] | Cohort | USA | 2009–2018 | 31 § | 16 # | 18 | Median 61 (21–80) # | 27 PDAC, 3 PNET, 1 SPP ** |
Bachellier et al. [12] | Cohort | France | 2008–2012 | 15 | 6 | 9 | 65 +/- 18 (46–83) | Locally advanced PDAC |
Al-Saeedi et al. [13] | Cohort | Germany | 2017–2019 | 10 | 5 | 5 | 64 +/- 8 | 9 PDAC, 1 PNET |
Oehme et al. [14] | Cohort | Germany | 2012–2017 | 11 | 8 | 3 | Median 65.1 (57–73.5) | 9 PDAC, 1 dedifferentiated, 1 pleomorphic |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Libia, A.; Marchese, T.; D’Ugo, S.; Piscitelli, P.; Castellana, F.; Clodoveo, M.L.; Zupo, R.; Spampinato, M.G. Use of Vascular Shunt at the Time of Pancreatectomy with Venous Resection: A Systematic Review. Cancers 2024, 16, 2361. https://doi.org/10.3390/cancers16132361
Libia A, Marchese T, D’Ugo S, Piscitelli P, Castellana F, Clodoveo ML, Zupo R, Spampinato MG. Use of Vascular Shunt at the Time of Pancreatectomy with Venous Resection: A Systematic Review. Cancers. 2024; 16(13):2361. https://doi.org/10.3390/cancers16132361
Chicago/Turabian StyleLibia, Annarita, Tiziana Marchese, Stefano D’Ugo, Prisco Piscitelli, Fabio Castellana, Maria Lisa Clodoveo, Roberta Zupo, and Marcello Giuseppe Spampinato. 2024. "Use of Vascular Shunt at the Time of Pancreatectomy with Venous Resection: A Systematic Review" Cancers 16, no. 13: 2361. https://doi.org/10.3390/cancers16132361
APA StyleLibia, A., Marchese, T., D’Ugo, S., Piscitelli, P., Castellana, F., Clodoveo, M. L., Zupo, R., & Spampinato, M. G. (2024). Use of Vascular Shunt at the Time of Pancreatectomy with Venous Resection: A Systematic Review. Cancers, 16(13), 2361. https://doi.org/10.3390/cancers16132361